/PRNewswire/ EpicentRx Inc. ("EpicentRx"), a clinical stage biopharmaceutical company, announced today the publication of a review article on its small.
/PRNewswire/ EpicentRx Inc. ("EpicentRx"), a late-stage biopharmaceutical company with platforms that treat and target multiple immune-mediated inflammatory.